NCT06798129

Brief Summary

This study aims to estimate the effect of extracorporeal treatments (ECTRs) on 28-day survival in patients with acute poisoning. The treatment strategy was receipt of ECTR (hemoperfusion, hemodialysis, continuous kidney replacement therapy, and/or or plasma exchange) versus a non-ECTR strategy.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,269

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Jan 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jan 2015Dec 2026

Study Start

First participant enrolled

January 1, 2015

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 23, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 29, 2025

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

December 5, 2025

Status Verified

November 1, 2025

Enrollment Period

9 years

First QC Date

January 23, 2025

Last Update Submit

November 27, 2025

Conditions

PoisoningExtracorporeal Treatment

Outcome Measures

Primary Outcomes (1)

  • Survival outcome

    28 days within the index date of presentation at emergency department

Interventions

Extracorporeal TreatmentPROCEDURE

Extracorporeal treatments include hemoperfusion, hemodialysis, continuous kidney replacement therapy, and plasma exchange.

Eligibility Criteria

Age12 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with acute poisoning

You may qualify if:

  • years of age and older
  • History of acute poisoning

You may not qualify if:

  • missing records in survival outcome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, 210008, China

Location

MeSH Terms

Conditions

Poisoning

Interventions

Extracorporeal Membrane Oxygenation

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders

Intervention Hierarchy (Ancestors)

Respiratory TherapyTherapeuticsExtracorporeal CirculationSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

January 23, 2025

First Posted

January 29, 2025

Study Start

January 1, 2015

Primary Completion

December 31, 2023

Study Completion (Estimated)

December 31, 2026

Last Updated

December 5, 2025

Record last verified: 2025-11

Locations

CN(1)